Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,678 JPY | -0.32% | +1.28% | -16.38% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
Business Summary
Number of employees: 3,534
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Domestic
75.2
%
| 117,540 | 70.7 % | 130,497 | 75.2 % | +11.02% |
International
24.4
%
| 39,676 | 23.9 % | 42,295 | 24.4 % | +6.60% |
Others
0.4
%
| 601 | 0.4 % | 662 | 0.4 % | +10.15% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
75.6
%
| 126,581 | 76.1 % | 131,160 | 75.6 % | +3.62% |
United States
9.8
%
| 16,474 | 9.9 % | 17,057 | 9.8 % | +3.54% |
China
7.9
%
| 12,482 | 7.5 % | 13,652 | 7.9 % | +9.37% |
Southeast Asia
4.6
%
| 7,493 | 4.5 % | 7,932 | 4.6 % | +5.86% |
Others
2.1
%
| 3,225 | 1.9 % | 3,653 | 2.1 % | +13.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chairman | 84 | 62-02-28 | |
Noriaki Hirao
DFI | Director of Finance/CFO | - | - |
President | 52 | 98-02-28 | |
Director/Board Member | 62 | 86-03-31 | |
Satoshi Yamane
BRD | Director/Board Member | 64 | 83-02-28 |
Yoshihiro Ogawa
SAM | Sales & Marketing | - | - |
Comptroller/Controller/Auditor | 64 | 03-06-30 | |
Fujito Owaki
PRN | Corporate Officer/Principal | - | - |
Naoki Ayabe
SAM | Sales & Marketing | - | - |
Hiroshi Goto
AUD | Comptroller/Controller/Auditor | 67 | 79-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Haruo Tsuji
BRD | Director/Board Member | 91 | 08-05-31 |
President | 52 | 98-02-28 | |
Chairman | 84 | 62-02-28 | |
Kunio Ito
BRD | Director/Board Member | 72 | 07-05-31 |
Satoshi Yamane
BRD | Director/Board Member | 64 | 83-02-28 |
Kaori Sasaki
BRD | Director/Board Member | 64 | 16-05-31 |
Director/Board Member | 62 | 86-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 78,050,000 | 46,707,145 ( 59.84 %) | 3,711,086 ( 4.755 %) | 59.84 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
3,846,586 | 4.93% | 129,494,587 $ | |
5,074,000 | 2.29% | 77,780,412 $ | |
MATSUKIYOCOCOKARA & CO. 0.30% | 1,270,908 | 0.30% | 20,485,512 $ |
PALTAC CORPORATION 0.94% | 600,000 | 0.94% | 16,313,718 $ |
TOPPAN INC. 0.07% | 230,000 | 0.07% | 5,894,941 $ |
HAKUHODO DY HOLDINGS INC 0.15% | 598,700 | 0.15% | 5,480,847 $ |
159,000 | 0.06% | 4,907,258 $ | |
TOHO HOLDINGS CO., LTD. 0.24% | 186,500 | 0.24% | 4,500,301 $ |
363,860 | 0.00% | 3,743,301 $ | |
MANDOM CORPORATION 0.72% | 346,000 | 0.72% | 3,086,327 $ |
Company contact information
Kobayashi Pharmaceutical Co., Ltd.
KDX Kobayashi Doshomachi Building 4-4-10 Dosho-machi
541-0045, Osaka
+81 6 6222 0142
http://www.kobayashi.co.jpGroup companies
Name | Category and Sector |
---|---|
Kobayashi Healthcare Europe Ltd.
Kobayashi Healthcare Europe Ltd. Pharmaceuticals: MajorHealth Technology Kobayashi Healthcare Europe Ltd. wholesales and distributes pharmaceutical goods. Its products include cura-heat, kool 'n' soothe, ice-eeze pack, hotHands, and clearwipe. The company is headquartered in London, the United Kingdom. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.38% | 2.73B | |
+10.21% | 379B | |
+1.61% | 120B | |
+11.13% | 72.61B | |
-15.04% | 63.19B | |
+1.83% | 52.85B | |
-10.15% | 37.49B | |
+1.40% | 32.93B | |
+5.32% | 16.61B | |
+4.17% | 14.54B |
- Stock Market
- Equities
- 4967 Stock
- Company Kobayashi Pharmaceutical Co., Ltd.